Structure and activity of human surfactant protein D from different natural sources.


Journal

American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229

Informations de publication

Date de publication:
01 07 2020
Historique:
pubmed: 21 5 2020
medline: 7 10 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

Surfactant protein D (SP-D) is a C-type lectin that participates in the innate immune defense of lungs. It binds pathogens through its carbohydrate recognition domain in a calcium-dependent manner. Human surfactant protein D (hSP-D) has been routinely obtained from bronchoalveolar lavage of patients suffering from pulmonary alveolar proteinosis (PAP) and from amniotic fluid (AF). As a consequence of the disease, hSP-D obtained from PAP is found in higher amounts and is mainly composed of higher order oligomeric forms. However, PAP-hSP-D has never been directly compared with nonpathological human protein in terms of structure and biological activity. Moreover, the quantitative distribution of the different hSP-D oligomeric forms in human protein obtained from a natural source has never been evaluated. In this work, we have determined the quantitative distribution of AF-hSP-D oligomers, characterized the sugars attached through the

Identifiants

pubmed: 32432921
doi: 10.1152/ajplung.00007.2020
doi:

Substances chimiques

Polysaccharides 0
Pulmonary Surfactant-Associated Protein D 0
Asparagine 7006-34-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

L148-L158

Auteurs

Raquel Arroyo (R)

Department of Biochemistry, Faculty of Biology, Complutense University, Madrid, Spain.
Research Institut "Hospital 12 de Octubre (imas12)", Madrid, Spain.

Mercedes Echaide (M)

Department of Biochemistry, Faculty of Biology, Complutense University, Madrid, Spain.
Research Institut "Hospital 12 de Octubre (imas12)", Madrid, Spain.

Robert Wilmanowski (R)

Glycotope GmbH, Berlin, Germany.

Alejandro Martín-González (A)

Department of Macromolecular Structures, National Center of Biotechnology, CSIC, Madrid, Spain.

Emma Batllori (E)

Research Institut "Hospital 12 de Octubre (imas12)", Madrid, Spain.
Department of Obstetrics and Gyneacology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Alberto Galindo (A)

Research Institut "Hospital 12 de Octubre (imas12)", Madrid, Spain.
Department of Obstetrics and Gyneacology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Fetal Medicine Unit-SAMID, Hospital Universitario 12 de Octubre, Madrid, Spain.

Jan S Rosenbaum (JS)

Research and Development Department, Airway Therapeutics LLC, Cincinnati, Ohio.

Fernando Moreno-Herrero (F)

Department of Macromolecular Structures, National Center of Biotechnology, CSIC, Madrid, Spain.

Paul S Kingma (PS)

Division of Neonatology and Pulmonary Biology, Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Jesús Pérez-Gil (J)

Department of Biochemistry, Faculty of Biology, Complutense University, Madrid, Spain.
Research Institut "Hospital 12 de Octubre (imas12)", Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH